Patents Assigned to Naprogenix, Inc.
  • Mutagenesis of plants for overproduction of selective estrogen receptor modulators
    Patent number: 9758788
    Abstract: Certain embodiments of the invention provide methods of selecting a mutant plant cell that overproduces a compound that activates an estrogen receptor (ER) beta but does not activate an ER alpha.
    Type: Grant
    Filed: August 7, 2015
    Date of Patent: September 12, 2017
    Assignee: Naprogenix, Inc.
    Inventors: John M. Littleton, Deane Falcone, Dustin Brown, Samir Gunjan, Trent Rogers